Simple jQuery Dropdowns
Please use this identifier to cite or link to this item:
Title: 2018 Kidney Disease: Improving Global Outcomes (KDIGO) Hepatitis C in Chronic Kidney Disease Guideline Implementation: Asia Summit Conference Report
Authors: Philip Kam Tao Li
Sunita Bavanandan
Rosmawati Mohamed
Cheuk Chun Szeto
Vincent Wai Sun Wong
Kai Ming Chow
Yock Young Dan
Chiu Ching Huang
Ching Lung Lai
Tawesak Tanwandee
Boon Wee Teo
Grace Lai Hung Wong
Eng Kiong Yeoh
Kunitoshi Iseki
Chi Bon Leung
Hyeong Cheon Park
Talerngsak Kanjanabuch
Wanhong Lu
James Fung
Jidong Jia
Eiichiro Kanda
Man Ching Law
Hong Liu
Ching Kong Loo
Siu Ka Mak
Sing Leung Lui
Hon Lok Tang
Angela Yee Moon Wang
Ming Lung Yu
Michael Cheung
Michel Jadoul
The University of Hong Kong, State Key Laboratory of Liver Research
Severance Hospital
Beijing Friendship Hospital, Capital Medical University
Kaohsiung Medical University Chung-Ho Memorial Hospital
China Medical University Hospital Taichung
National University Hospital, Singapore
University of Malaya
Chulalongkorn University
Yong Loo Lin School of Medicine
Kuala Lumpur Hospital
Prince of Wales Hospital Hong Kong
Kwong Wah Hospital
Xi'an Jiaotong University
Central South University
Princess Margaret Hospital Hong Kong
Cliniques Universitaires Saint-Luc
Faculty of Medicine, Siriraj Hospital, Mahidol University
Tung Wah Hospital
Kawasaki Medical College
The University of Hong Kong
Chinese University of Hong Kong
Kidney Disease: Improving Global Outcomes (KDIGO)
Tomishiro Central Hospital
Keywords: Medicine
Issue Date: 1-Aug-2020
Citation: Kidney International Reports. Vol.5, No.8 (2020), 1129-1138
Abstract: © 2020 International Society of Nephrology In 2018, Kidney Disease: Improving Global Outcomes (KDIGO) published a clinical practice guideline on the prevention, diagnosis, evaluation, and treatment of hepatitis C virus (HCV) infection in chronic kidney disease (CKD). The guideline synthesized recent advances, especially in HCV therapeutics and diagnostics, and provided clinical recommendations and suggestions to aid healthcare providers and improve care for CKD patients with HCV. To gain insight into the extent that the 2018 guideline has been adopted in Asia, KDIGO convened an HCV Implementation Summit in Hong Kong. Participants included nephrologists, hepatologists, and nurse consultants from 8 Southeast Asian countries or regions with comparable high-to-middle economic ranking by the World Bank: mainland China, Hong Kong, Japan, Malaysia, Singapore, South Korea, Taiwan, and Thailand. Through presentations and discussions, meeting participants described regional practice patterns related to the KDIGO HCV in CKD guideline, identified barriers to implementing the guideline, and developed strategies for overcoming the barriers in Asia and around the world.
ISSN: 24680249
Appears in Collections:Scopus 2020

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.